Multi-dimensional investment strategy to capitalise on significant opportunities
An investment methodology that goes beyond the formulaic. Decision-making for the good of the Fund, not compromised by ‘loyalty’ to investee companies.
To invest in fast growing and/or high potential life sciences businesses
Based predominantly in the UK, wider Europe and the US
Target Shareholder Returns of 20%
Decades of board level experience
Our board believe the application of “Intuition” is fundamental when making investment decisions – presenting an opportunity for investors to tap into this wealth of experience.